about
Fertility preservation in women with cervical, endometrial or ovarian cancersThe ganglioside GM3 is associated with cisplatin-induced apoptosis in human colon cancer cellsWithholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case Report.Immature uterine teratoma associated with uterine inversion.Paraneoplastic limbic encephalitis cured with resection of an adnexal mass.Adult granulosa cell tumor associated with endometrial carcinoma: a case report.Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovaryPure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.Tailored therapy and long-term surveillance of malignant germ cell tumors in the female genital system: 10-year experienceCardiac metastasis from yolk sac tumor: case report and reviewPrimary ovary choriocarcinoma: individual DNA polymorphic analysis as a strategy to confirm diagnosis and treatmentOncofertility in Canada: the impact of cancer on fertilityManagement of bilateral malignant ovarian germ cell tumors: Experience of a single instituteMolecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.Clinical and radiologic signs of relapsed ovarian germ cell tumor: tissue is the issue.Laparoscopic treatment of a Yolk Sac Tumor: case report and literature review.S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric ovarian tumors: a novel treatment approach.Malignant mixed ovarian germ cell tumor with embryonal component.The impact of cisplatinum-based chemotherapy on ventricular function and cardiovascular risk factors in female survivors after malignant germ cell cancer.The role of staging surgery in the treatment of apparent early-stage malignant ovarian germ cell tumours.Ovarian cystectomy in the treatment of apparent early-stage immature teratoma.Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery.Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.Treatment and survival patterns for germ cell tumors among 13- to 24-year olds in Yorkshire, UK.Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998-2012.Advanced germ cell malignancies of the ovary: should neo-adjuvant chemotherapy be the first line of treatment?Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.High-dose chemotherapy and stem-cell rescue for salvage therapy for relapsed malignant mixed ovarian germ cell tumor: A case report.Reproductive function assessment after surgery plus chemotherapy for germ cell ovarian tumors (MOGCT): novel clues deriving from the field of fertility preservation.Germ cell tumors: Treatment consensus across all age groups through MaGIC [Malignant Germ Cell International Collaborative].The application of 18F-FDG PET/CT in ovarian immature teratomas when pathological examination results contradict clinical observations: a case report.Significance of the Complete Surgical Staging of Stage I Malignant Ovarian Germ Cell Tumors.Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors.Malignant germ cell tumors associated with Swyer syndrome.Malignant mixed ovarian germ cell tumor composed of immature teratoma, yolk sac tumor and embryonal carcinoma harboring an EGFR mutation: a case reportOvarian yolk sac tumor in postmenopausal females: A case series and a literature review
P2860
Q26741087-332E2ADC-EF51-494D-B1C3-8399DACF700BQ33609838-08760677-D5A7-4270-9144-46CE3C0CF7D3Q34059628-096C8153-7EBA-458B-8E3F-0555A40898A0Q34259207-7D60B753-E026-429B-A5B8-C82EF1DE97BCQ34466636-0C5AA143-E355-4A1B-8C3A-B596710C01D4Q35170597-29E29813-AA1F-468C-9AC0-F1CF8D7E8FAAQ35208062-2BA225E0-E224-4A06-8F45-F4BE1098E5A8Q36217531-02755952-DBA1-4057-B981-83B8496B7992Q36772932-4ECF9C9D-8E3A-43DE-B062-A43A13A46F3BQ36831612-1472FA2A-949A-4110-B987-B3829B9671A2Q37034638-384EB8B2-A5DD-472B-A1E6-9E48B79582CBQ37056902-4681A184-AC1E-4F8E-A309-0EE267DA11E7Q37106649-E65B09FD-B4D9-4DA3-961C-32B122FE1CC5Q37209628-983A4322-6E04-48F0-907D-ECB81A9B8E5AQ37270307-7235737A-261D-468E-B425-3268FCEF8116Q37313347-218F3383-C66B-4C0D-9C9C-2BBDBEDC33EFQ37383301-BE953575-FFBD-4E14-85FA-B3DF5E2B2D34Q37397505-96201854-3574-41E4-8332-8BBADCC6B4E7Q37418313-CAC54A89-6752-448F-99FB-6E1C0DB04B9DQ38611589-A84F15EE-1DA5-45C2-85AC-C1D260197299Q38823006-F5D36ECA-DC6F-4A7F-8064-E32B59A2926BQ38833941-5EB8ABB6-0B69-46E2-BDD9-220AB6E43C55Q38847079-369CC8A0-57A6-4A9D-8FDF-7CB5DF8FB0D4Q39298713-7CD28DA6-3A5D-4744-9F7E-BB85A549F09BQ39805629-D48F38B3-44FE-4448-AE45-AB41423CF2E0Q40737174-F13FB33A-78B7-450E-AC69-F78C4063DB30Q43178527-5D857226-74C6-4439-ACB4-2EDF04E7E996Q44986798-3F2946FF-37F8-4B27-B8B8-040A58A84132Q47095867-C5B66796-D892-4655-BD85-718E71391DFFQ48597947-F2694DC2-A74F-4900-A0C9-087AFFAD9BEAQ48930305-2C7BC0D4-E596-49BB-B040-11A1D0EE8FEEQ49487681-87A86454-60FA-4D17-B7BE-12496E0391BDQ50858642-17DCDEF2-9F4E-401D-8BBB-BFF1AAAEBC31Q50957685-8F6E818F-07A1-49A9-A533-B32A519F6FB2Q51517868-D8141190-7C2D-4CBD-8076-79C3812891A3Q57815599-AAB484A2-F706-4872-9D05-85EBF0F4B273Q58768714-0DC9B782-06F7-48E2-AA8E-3896A6EA5D93
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Management of ovarian germ cell tumors.
@en
type
label
Management of ovarian germ cell tumors.
@en
prefLabel
Management of ovarian germ cell tumors.
@en
P356
P1476
Management of ovarian germ cell tumors.
@en
P2093
David M Gershenson
P304
P356
10.1200/JCO.2007.10.8738
P407
P577
2007-07-01T00:00:00Z